Rotteveel Adriënne H, Lambooij Mattijs S, van de Rijt Joline J A, van Exel Job, Moons Karel G M, de Wit G Ardine
Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720, BA, Bilthoven, the Netherlands.
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, PO Box 1738, 3000, DR, Rotterdam, the Netherlands.
BMC Health Serv Res. 2021 Apr 1;21(1):298. doi: 10.1186/s12913-021-06298-3.
Recent attempts of active disinvestment (i.e. withdrawal of reimbursement by means of a policy decision) of reimbursed healthcare interventions in the Netherlands have differed in their outcome: some attempts were successful, with interventions actually being disinvested. Other attempts were terminated at some point, implying unsuccessful disinvestment. This study aimed to obtain insight into recent active disinvestment processes, and to explore what aspects affect their outcome.
Semi-structured interviews were conducted from January to December 2018 with stakeholders (e.g. patients, policymakers, physicians) who were involved in the policy process of five cases for which the full or partial withdrawal of reimbursement was considered in the Netherlands between 2007 and 2017: benzodiazepines, medication for Fabry disease, quit smoking programme, psychoanalytic therapy and maternity care assistance. These cases covered both interventions that were eventually disinvested and interventions for which reimbursement was maintained after consideration. Interviews were transcribed verbatim, double coded and analyzed using thematic analysis.
The 37 interviews showed that support for disinvestment from stakeholders, especially from healthcare providers and policymakers, strongly affected the outcome of the disinvestment process. Furthermore, the institutional role of stakeholders as legitimized by the Dutch health insurance system, their financial interests in maintaining or discontinuing reimbursement, and the possibility to relieve the consequences of disinvestment for current patients affected the outcome of the disinvestment process as well. A poor organization of patient groups may make it difficult for patients to exert pressure, which may contribute to successful disinvestment. No evidence was found of a consistent role of the formal Dutch package criteria (i.e. effectiveness, cost-effectiveness, necessity and feasibility) in active disinvestment processes.
Contextual factors as well as the possibility to relieve the consequences of disinvestment for current patients are important determinants of the outcome of active disinvestment processes. These results provide insight into active disinvestment processes and their determinants, and provide guidance to policymakers for a potentially more successful approach for future active disinvestment processes.
荷兰近期对已报销医疗干预措施进行主动撤资(即通过政策决定撤销报销)的尝试结果各异:一些尝试取得成功,相关干预措施确实被撤资。其他尝试在某个阶段终止,意味着撤资未成功。本研究旨在深入了解近期的主动撤资过程,并探究哪些因素会影响其结果。
2018年1月至12月,对参与2007年至2017年期间荷兰五项考虑全部或部分撤销报销政策过程的利益相关者(如患者、政策制定者、医生)进行了半结构化访谈:苯二氮䓬类药物、法布里病用药、戒烟计划、心理分析治疗和产妇护理援助。这些案例涵盖了最终被撤资的干预措施以及经考虑后仍维持报销的干预措施。访谈内容逐字转录、进行双重编码,并采用主题分析法进行分析。
37次访谈表明,利益相关者,尤其是医疗服务提供者和政策制定者对撤资的支持,对撤资过程的结果有很大影响。此外,荷兰医疗保险系统赋予利益相关者的机构角色、他们在维持或终止报销方面的经济利益,以及减轻撤资对当前患者影响的可能性,也会影响撤资过程的结果。患者群体组织不善可能使患者难以施加压力,这可能有助于撤资成功。未发现荷兰正式套餐标准(即有效性、成本效益、必要性和可行性)在主动撤资过程中发挥一致作用的证据。
背景因素以及减轻撤资对当前患者影响的可能性是主动撤资过程结果的重要决定因素。这些结果深入了解了主动撤资过程及其决定因素,并为政策制定者提供指导,以便在未来的主动撤资过程中采取可能更成功的方法。